Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward Counties, Florida, June-August 2016.
During the first 6 months of 2016, large outbreaks of Zika virus disease caused by local mosquito-borne transmission occurred in Puerto Rico and other U.S. territories, but local mosquito-borne transmission was not identified in the continental United States (1,2). As of July 22, 2016, the Florida Department of Health had identified 321 Zika virus disease cases among Florida residents and visitors, all occurring in either travelers from other countries or territories with ongoing Zika virus transmission or sexual contacts of recent travelers.* During standard case investigation of persons with compatible illness and laboratory evidence of recent Zika virus infection (i.e., a specimen positive by real-time reverse transcription-polymerase chain reaction [rRT-PCR], or positive Zika immunoglobulin M [IgM] with supporting dengue serology [negative for dengue IgM antibodies and positive for dengue IgG antibodies], or confirmation of Zika virus neutralizing antibodies by plaque reduction neutralization testing [PRNT]) (3), four persons were identified in Broward and Miami-Dade counties whose infections were attributed to likely local mosquito-borne transmission. Two of these persons worked within 120 meters (131 yards) of each other but had no other epidemiologic connections, suggesting the possibility of a local community-based outbreak. Further epidemiologic and laboratory investigations of the worksites and surrounding neighborhood identified a total of 29 persons with laboratory evidence of recent Zika virus infection and likely exposure during late June to early August, most within an approximate 6-block area. In response to limited impact on the population of Aedes aegypti mosquito vectors from initial ground-based mosquito control efforts, aerial ultralow volume spraying with the organophosphate insecticide naled was applied over a 10 square-mile area beginning in early August and alternated with aerial larviciding with Bacillus thuringiensis subspecies israelensis (Bti), a group biologic control agent, in a central 2 square-mile area. No additional cases were identified after implementation of this mosquito control strategy. No increases in emergency department (ED) patient visits associated with aerial spraying were reported, including visits for asthma, reactive airway disease, wheezing, shortness of breath, nausea, vomiting, or diarrhea. Local and state health departments serving communities where Ae. aegypti, the primary vector of Zika virus, is found should continue to actively monitor for local transmission of the virus.(†).
Anna
A
Likos
Isabel
I
Griffin
Andrea M
AM
Bingham
Danielle
D
Stanek
Marc
M
Fischer
Stephen
S
White
Janet
J
Hamilton
Leah
L
Eisenstein
David
D
Atrubin
Prakash
P
Mulay
Blake
B
Scott
Patrick
P
Jenkins
Danielle
D
Fernandez
Edhelene
E
Rico
Leah
L
Gillis
Reynald
R
Jean
Marshall
M
Cone
Carina
C
Blackmore
Janet
J
McAllister
Chalmers
C
Vasquez
Lillian
L
Rivera
Celeste
C
Philip
D000328:Adult; D000818:Animals; D009033:Culicidae / Q000821:virology*; D004196:Disease Outbreaks / Q000517:prevention & control; D005260:Female; D005431:Florida / Q000453:epidemiology; D006801:Humans; D007303:Insect Vectors / Q000821:virology*; D008297:Male; D009032:Mosquito Control / Q000379:methods / Q000458:organization & administration; D000071244:Zika Virus / Q000302:isolation & purification*; D000071243:Zika Virus Infection / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*